vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($276.3M vs $142.0M, roughly 1.9× Oncology Institute, Inc.). PATHWARD FINANCIAL, INC. runs the higher net margin — 26.4% vs -5.3%, a 31.7% gap on every dollar of revenue. Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 21.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CASH vs TOI — Head-to-Head

Bigger by revenue
CASH
CASH
1.9× larger
CASH
$276.3M
$142.0M
TOI
Higher net margin
CASH
CASH
31.7% more per $
CASH
26.4%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
21.0%
CASH

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CASH
CASH
TOI
TOI
Revenue
$276.3M
$142.0M
Net Profit
$72.9M
$-7.5M
Gross Margin
Operating Margin
-4.9%
Net Margin
26.4%
-5.3%
Revenue YoY
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$3.35
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
TOI
TOI
Q1 26
$276.3M
Q4 25
$173.1M
$142.0M
Q3 25
$186.7M
$136.6M
Q2 25
$195.8M
$119.8M
Q1 25
$274.8M
$104.4M
Q4 24
$182.6M
$100.3M
Q3 24
$179.5M
$99.9M
Q2 24
$188.6M
$98.6M
Net Profit
CASH
CASH
TOI
TOI
Q1 26
$72.9M
Q4 25
$35.2M
$-7.5M
Q3 25
$38.8M
$-16.5M
Q2 25
$42.1M
$-17.0M
Q1 25
$75.0M
$-19.6M
Q4 24
$30.0M
$-13.2M
Q3 24
$33.5M
$-16.1M
Q2 24
$44.9M
$-15.5M
Operating Margin
CASH
CASH
TOI
TOI
Q1 26
Q4 25
24.6%
-4.9%
Q3 25
25.9%
-5.9%
Q2 25
24.1%
-9.4%
Q1 25
33.2%
-9.5%
Q4 24
19.8%
-11.9%
Q3 24
20.9%
-13.9%
Q2 24
27.1%
-16.6%
Net Margin
CASH
CASH
TOI
TOI
Q1 26
26.4%
Q4 25
20.3%
-5.3%
Q3 25
20.8%
-12.1%
Q2 25
21.5%
-14.2%
Q1 25
27.3%
-18.8%
Q4 24
16.4%
-13.1%
Q3 24
18.7%
-16.1%
Q2 24
23.8%
-15.7%
EPS (diluted)
CASH
CASH
TOI
TOI
Q1 26
$3.35
Q4 25
$1.57
$-0.04
Q3 25
$1.69
$-0.14
Q2 25
$1.81
$-0.15
Q1 25
$3.14
$-0.21
Q4 24
$1.23
$-0.14
Q3 24
$1.34
$-0.18
Q2 24
$1.78
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$157.6M
Total DebtLower is stronger
$59.5M
Stockholders' EquityBook value
$850.7M
$-15.7M
Total Assets
$7.1B
$164.7M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
TOI
TOI
Q1 26
$157.6M
Q4 25
$331.2M
Q3 25
$120.6M
Q2 25
$258.3M
Q1 25
$254.2M
Q4 24
$597.4M
Q3 24
$158.3M
Q2 24
$298.9M
$9.9M
Total Debt
CASH
CASH
TOI
TOI
Q1 26
$59.5M
Q4 25
$33.5M
Q3 25
$33.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
Q3 24
$33.4M
Q2 24
$33.3M
Stockholders' Equity
CASH
CASH
TOI
TOI
Q1 26
$850.7M
Q4 25
$854.5M
$-15.7M
Q3 25
$858.0M
$-12.3M
Q2 25
$819.0M
$-9.0M
Q1 25
$814.7M
$5.1M
Q4 24
$758.3M
$3.6M
Q3 24
$822.5M
$15.5M
Q2 24
$748.4M
$29.2M
Total Assets
CASH
CASH
TOI
TOI
Q1 26
$7.1B
Q4 25
$7.6B
$164.7M
Q3 25
$7.2B
$163.6M
Q2 25
$7.2B
$159.8M
Q1 25
$7.0B
$164.0M
Q4 24
$7.6B
$172.7M
Q3 24
$7.5B
$179.2M
Q2 24
$7.5B
$179.6M
Debt / Equity
CASH
CASH
TOI
TOI
Q1 26
0.07×
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
TOI
TOI
Operating Cash FlowLast quarter
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
TOI
TOI
Q1 26
Q4 25
$108.3M
$3.2M
Q3 25
$303.7M
$-12.6M
Q2 25
$30.4M
$-10.2M
Q1 25
$188.3M
$-5.0M
Q4 24
$-71.7M
$4.2M
Q3 24
$143.1M
$819.0K
Q2 24
$113.2M
$-15.7M
Free Cash Flow
CASH
CASH
TOI
TOI
Q1 26
Q4 25
$104.1M
$2.2M
Q3 25
$300.3M
$-13.2M
Q2 25
$27.7M
$-11.4M
Q1 25
$184.7M
$-5.3M
Q4 24
$-73.8M
$2.4M
Q3 24
$138.8M
$417.0K
Q2 24
$111.0M
$-17.5M
FCF Margin
CASH
CASH
TOI
TOI
Q1 26
Q4 25
60.1%
1.5%
Q3 25
160.9%
-9.7%
Q2 25
14.1%
-9.5%
Q1 25
67.2%
-5.1%
Q4 24
-40.4%
2.4%
Q3 24
77.3%
0.4%
Q2 24
58.8%
-17.7%
Capex Intensity
CASH
CASH
TOI
TOI
Q1 26
Q4 25
2.4%
0.7%
Q3 25
1.8%
0.4%
Q2 25
1.4%
1.0%
Q1 25
1.3%
0.3%
Q4 24
1.1%
1.8%
Q3 24
2.4%
0.4%
Q2 24
1.2%
1.9%
Cash Conversion
CASH
CASH
TOI
TOI
Q1 26
Q4 25
3.08×
Q3 25
7.83×
Q2 25
0.72×
Q1 25
2.51×
Q4 24
-2.39×
Q3 24
4.27×
Q2 24
2.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Noninterest Income$151.2M55%
Net Interest Income$125.1M45%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons